{"section":{"filename":"s2401.html","chapter":"2400","section_number":"2401","title":"Introduction","revision_tag":"R-01.2024","bytes":36534,"sha256":"aa7cd96e92ee971133b7877f87e0df1a0a69e04fcbed096fb23ad4d3bbd52126","subsection_count":0,"max_depth":0,"subsections":[]},"quality":"structured","cited_authorities":null,"structured_data":{"nodes":[{"id":"se_26jkbcjv","node_type":"section","corpus_id":"mpep-e9r01-2024-html","akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2401","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2401","opaque_url":"https://mpep.io/n/se_26jkbcjv","effective_range":{"start_revision":"R-01.2024","end_revision":null},"rendered_text_html":"","rendered_text_plain":"","provenance":{"source_file":"s2401.html","source_anchor":"d0e240556","source_sha256":"aa7cd96e92ee971133b7877f87e0df1a0a69e04fcbed096fb23ad4d3bbd52126","discovery_pass":"pass2"},"section_number":"2401","chapter":"2400","depth":0,"title":"Introduction","revision_tag":"R-01.2024","children_ids":["pb_qip7wwgo"]},{"id":"pb_qip7wwgo","node_type":"prose_block","corpus_id":"mpep-e9r01-2024-html","akn_urn":"/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2401__pb_qip7wwgo","canonical_url":"https://mpep.io/akn/us/statement/manual/uspto/2024/mpep/eng@2024-02-29!sec_2401#pb_qip7wwgo","opaque_url":"https://mpep.io/n/pb_qip7wwgo","effective_range":{"start_revision":"R-01.2024","end_revision":null},"rendered_text_html":"This chapter provides guidance on the practices and procedures pertaining\n                        to the rules for deposits of biological materials for patent purposes (<b><a href=\"mpep-9020-appx-r.html#d0e333189\">37 CFR 1.801</a></b> -\n                        <b><a href=\"mpep-9020-appx-r.html#d0e333576\">\n                              1.809</a></b>) and the rules for the requirements for patent applications\n                        containing nucleotide sequence and/or amino acid sequence disclosures under World\n                        Intellectual Property Organization (WIPO) Standard ST.25 (<b><a href=\"mpep-9020-appx-r.html#d0e333653\">37 CFR 1.821</a></b> -\n                        <b><a href=\"mpep-9020-appx-r.html#d0e334511\">\n                              1.825</a></b>) and WIPO Standard ST.26 (<b><a href=\"mpep-9020-appx-r.html#ar_d35d57_1bdc8_2b8\">37 CFR\n                              1.831</a></b> - <b><a href=\"mpep-9020-appx-r.html#ar_d35d57_1be4d_1f4\">1.835</a></b>). \n                     ","rendered_text_plain":"This chapter provides guidance on the practices and procedures pertaining to the rules for deposits of biological materials for patent purposes (37 CFR 1.801 - 1.809) and the rules for the requirements for patent applications containing nucleotide sequence and/or amino acid sequence disclosures under World Intellectual Property Organization (WIPO) Standard ST.25 (37 CFR 1.821 - 1.825) and WIPO Standard ST.26 (37 CFR 1.831 - 1.835).","provenance":{"source_file":"s2401.html","source_anchor":"d0e240560","source_sha256":"aa7cd96e92ee971133b7877f87e0df1a0a69e04fcbed096fb23ad4d3bbd52126","discovery_pass":"pass2"},"kind":"narrative","host_section_id":"se_26jkbcjv"}],"edges":[]}}